After launching on the Base network, Aubrai's current market cap is $9 million, with a 3-hour trading volume of $6.4 million.
According to ChainCatcher, GMGN data shows that the first BioAgent Launch project of Bio Protocol, Aubrai, saw its market capitalization on the Base network briefly surpass 20 million USD before falling back, and is now reported at 9 million USD, with a trading volume of 6.4 million USD within three hours of launch.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
DRW and Marex complete OTC swap referencing tokenized S&P iBoxx Index
Jensen Huang’s first stop in Europe is Paris: investing $2 billions in one week, funding four French AI startups
Nvidia has invested in the French startups Doctolib and Genesis AI, but the amount of the investment has not been disclosed.

Tom Lee Says AI Is in 1997, Not 1999: Peak Bubble Could Be 2033

